Literature DB >> 20563858

The realm of microRNAs in cancers.

Nuray Varol1, Ece Konac, O Serhat Gurocak, Sinan Sozen.   

Abstract

MicroRNAs (miRNAs) are members of the non-protein coding RNA family. miRNAs, which can regulate genes on transcriptomic level through either degrading the target messenger RNA (mRNA) or suppressing the protein synthesis, also take part in a number of biological functions that involve development, differentiation, proliferation and apoptosis. The mutations and polymorphisms in the expression levels of miRNA genes or alterations in their epigenetic mechanisms may play their roles in the formation of malignancies. Increasing evidence shows that aberrant miRNA expression profiles are present in a variety of cancers. Therefore, it has been suggested that these profiles could be useful for diagnosis and classification of different tumor types and that these small RNAs might provide significant opportunities for the development of future miRNA-based therapies. In this review, we aimed to look into the realm of miRNAs, which is a recent area of research, appraise their biological activities on molecular level and their probable benefits on clinical practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20563858     DOI: 10.1007/s11033-010-0205-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  90 in total

Review 1.  P bodies: at the crossroads of post-transcriptional pathways.

Authors:  Ana Eulalio; Isabelle Behm-Ansmant; Elisa Izaurralde
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

2.  A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

Authors:  Francesco Fazi; Alessandro Rosa; Alessandro Fatica; Vania Gelmetti; Maria Laura De Marchis; Clara Nervi; Irene Bozzoni
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

3.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

4.  Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Authors:  Elizabeth S Raveche; Erica Salerno; Brian J Scaglione; Vijaya Manohar; Fatima Abbasi; Yi-Chu Lin; Torgny Fredrickson; Pablo Landgraf; Sumant Ramachandra; Konrad Huppi; Jorge R Toro; Vincent E Zenger; Robert A Metcalf; Gerald E Marti
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

5.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

8.  Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.

Authors:  U Lehmann; B Hasemeier; M Christgen; M Müller; D Römermann; F Länger; H Kreipe
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

9.  Human polymorphism at microRNAs and microRNA target sites.

Authors:  Matthew A Saunders; Han Liang; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

10.  A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.

Authors:  Sandrine Tchatchou; Anke Jung; Kari Hemminki; Christian Sutter; Barbara Wappenschmidt; Peter Bugert; Bernhard H F Weber; Dieter Niederacher; Norbert Arnold; Raymonda Varon-Mateeva; Nina Ditsch; Alfons Meindl; Rita K Schmutzler; Claus R Bartram; Barbara Burwinkel
Journal:  Carcinogenesis       Date:  2008-11-20       Impact factor: 4.944

View more
  14 in total

Review 1.  Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Authors:  Yogesh Dwivedi
Journal:  J Chem Neuroanat       Date:  2011-04-14       Impact factor: 3.052

2.  Comprehensive gene and microRNA expression profiling reveals the crucial role of hsa-let-7i and its target genes in colorectal cancer metastasis.

Authors:  Peng Zhang; Yanlei Ma; Feng Wang; Jianjun Yang; Zhihua Liu; Jiayuan Peng; Huanlong Qin
Journal:  Mol Biol Rep       Date:  2011-05-29       Impact factor: 2.316

Review 3.  [Research progress of miRNAs targeting GSK-3β in regulation of hepatocellular carcinoma invasion and metastasis].

Authors:  Song-Qi He; Bin Wen; Guan-Xin Chen; Hai-Tao Sun; Jia-Ling Sun; Xue-Mei Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

4.  Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?

Authors:  Barbara Seliger; Simon Jasinski; Sven P Dressler; Francesco M Marincola; Christian V Recktenwald; Ena Wang; Rudolf Lichtenfels
Journal:  J Proteome Res       Date:  2011-01-07       Impact factor: 4.466

5.  MiRNA-mediated tumor specific delivery of TRAIL reduced glioma growth.

Authors:  Yongli Bo; Guocai Guo; Weicheng Yao
Journal:  J Neurooncol       Date:  2013-01-22       Impact factor: 4.130

Review 6.  Salivary microRNAs and oral cancer detection.

Authors:  Janice M Yoshizawa; David T W Wong
Journal:  Methods Mol Biol       Date:  2013

Review 7.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

8.  An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.

Authors:  A James Watkins; Rifat A Hamoudi; Naiyan Zeng; Qingguo Yan; Yuanxue Huang; Hongxiang Liu; Jianzhong Zhang; Esteban Braggio; Rafael Fonseca; Laurence de Leval; Peter G Isaacson; Andrew Wotherspoon; Ellen D McPhail; Ahmet Dogan; Ming-Qing Du
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

9.  Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression.

Authors:  Tetsuo Hirano; Ryoko Yoshikawa; Hironori Harada; Yuka Harada; Atsuhiko Ishida; Takeshi Yamazaki
Journal:  Mol Cancer       Date:  2015-04-19       Impact factor: 27.401

10.  miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1.

Authors:  Yawei Huang; Jiatao Liu; Lulu Fan; Fang Wang; Hanqing Yu; Wei Wei; Guoping Sun
Journal:  Onco Targets Ther       Date:  2016-03-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.